Daniel Grima
Daniel Grima publishes mostly in Economics and Econometrics, Oncology and Epidemiology, on topics such as Health Systems, Economic Evaluations, Quality of Life, Economic and Financial Impacts of Cancer and Pharmaceutical Economics and Policy.
- World rank
- #1,574,716 of 1,633,909 ranked researchers
- Rank in Canada
- #38,146 of 38,960
- Works
- 17
- Citations
- 3
- Citations per work
- 0.2
What does Daniel Grima research?
Shares of their own output, by the field each of their topics belongs to. The grey slice is everything not listed.
- 1Economics and Econometrics39% of their works
- 2Oncology13% of their works
- 3Epidemiology10% of their works
- 4Molecular Biology6% of their works
- 5Nephrology6% of their works
- 6Pulmonary and Respiratory Medicine6% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Economic and Financial Impacts of Cancer
- Pharmaceutical Economics and Policy
- Cancer Genomics and Diagnostics
- Hepatitis B Virus Studies
- Lung Cancer Treatments and Mutations
- Molecular Biology Techniques and Applications
- Amyloidosis: Diagnosis, Treatment, Outcomes
Which keywords describe Daniel Grima's research?
The keywords of their largest research topics: Cost-effectiveness Analysis, Quality of Life, Cost of Care, Financial Toxicity, Targeted Therapy, Drug Development Costs, Generic Drugs and ALK Inhibitors.
- Real-Time PCR
- Cardiac Amyloidosis
- Hepatitis B Virus
- Chronic Hepatitis B
- ALK Inhibitors
- Drug Development Costs
- Financial Toxicity
- Quality of Life
- Cost-effectiveness Analysis
- Cost of Care
- Targeted Therapy
- Generic Drugs
- Cancer Genomics
- EGFR Mutations
- Mutational Signatures
- Quantitative
- Transthyretin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 17 words, with their numbers
- Cost-effectiveness Analysis51 topic
- Quality of Life51 topic
- Cost of Care41 topic
- Financial Toxicity41 topic
- Targeted Therapy42 topics
- Drug Development Costs31 topic
- Generic Drugs31 topic
- ALK Inhibitors21 topic
- Cancer Genomics21 topic
- Chronic Hepatitis B21 topic
- EGFR Mutations21 topic
- Hepatitis B Virus21 topic
- Mutational Signatures21 topic
- Cardiac Amyloidosis11 topic
- Quantitative11 topic
- Real-Time PCR11 topic
- Transthyretin11 topic
Where does Daniel Grima work?
Daniel Grima's main affiliation in the publication record is AstraZeneca (Canada), Canada.
How many publications and citations does Daniel Grima have?
Science Explorer counts 17 works and 3 citations for Daniel Grima, ranking #1,574,716 of 1,633,909 researchers worldwide on the composite score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics are in the interactive view on the map. Is this your page? Request a correction or removal.